Experienced in Dyserythropoietic Anemia and Thrombocytopenia

Montserrat Rovira

Barcelona, CT, ES 
Experienced in Dyserythropoietic Anemia and Thrombocytopenia
Barcelona, CT, ES 
OverviewLocationsClinical Research

Overview

Montserrat Rovira practices in Barcelona, Spain. Ms. Rovira is rated as an Experienced expert by MediFind in the treatment of Dyserythropoietic Anemia and Thrombocytopenia. Her top areas of expertise are Graft Versus Host Disease (GvHD), Febrile Neutropenia, Leukemia, Bone Marrow Transplant, and Bone Graft.

Her clinical research consists of co-authoring 200 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Dyserythropoietic Anemia and Thrombocytopenia.

Gender
Female

Locations

Barcelona, CT, Spain
Other Locations
Madrid, MD 28040, Spain
Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Prospective Multicenter Open-label, Not Controlled Phase Ib-II Clinical Trial to Assess the Safety and Immunologic Efficacy of Virus-specific T Lymphocytes From the Best Donor in Receptors of Hematopoietic Progenitor Allogeneic Transplant
A Prospective Multicenter Open-label, Not Controlled Phase Ib-II Clinical Trial to Assess the Safety and Immunologic Efficacy of Virus-specific T Lymphocytes From the Best Donor in Receptors of Hematopoietic Progenitor Allogeneic Transplant
Enrollment Status: Completed
Publish Date: January 24, 2024
Intervention Type: Drug
Study Drug: Activated T-lymphocytes
Study Phase: Phase 1/Phase 2

200 Total Publications

Endothelial activation and stress index (EASIX) to predict engraftment syndrome after autologous hematopoietic cell transplantation in patients with multiple myeloma. A single center experience.
Endothelial activation and stress index (EASIX) to predict engraftment syndrome after autologous hematopoietic cell transplantation in patients with multiple myeloma. A single center experience.
Journal: Leukemia & lymphoma
Published: October 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Rovira's expertise for a condition
ConditionClose
View All 13 Advanced Conditions
View All 27 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile